Eli Lilly and Company & Donald Trump
17 shared events · Importance 7 · Last updated Apr 13, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Donald Trump: Donald Trump's comments about a potential end to the Middle East conflict influenced market sentiment, leading to speculation about peace.
Apr 01, 2026 · 14 articles
Domestic
Eli Lilly and Company: Eli Lilly and Company, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Donald Trump: Donald Trump announced new tariffs on various imported goods, aiming to boost domestic manufacturing and reduce the budget deficit, despite warnings of increased inflation and harm to consumers.
Sep 26, 2025 · 7 articles
Regulatory
Eli Lilly and Company: Eli Lilly and Company agreed to lower prices for its obesity drug Zepbound and will sell a starter dose for $299 a month, with additional doses up to $449, representing $50 reductions from current direct-to-patient prices. Its sales of Zepbound have tripled this year to over $9 billion.
Nov 06, 2025 · 6 articles
Business
Eli Lilly and Company: Eli Lilly and Company faces increased competition with Novo Nordisk's Wegovy pill launch, potentially impacting its market dominance in weight-loss drugs. Its shares fell following the announcement.
Jan 05, 2026 · 7 articles
Regulatory
Eli Lilly and Company: Eli Lilly and Company is mentioned as another drugmaker that has recently announced sizeable investments in the United States.
Apr 22, 2025 · 6 articles
Domestic
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
NEWSDESK
Explore this relationship live
Track how Eli Lilly and Company and Donald Trump interact across events, view sentiment trends, and discover connected entities.
Open Dashboard